表紙
市場調查報告書

微生物定序的全球市場

Global Microbiome Sequencing Market

出版商 BCC Research 商品編碼 866726
出版日期 內容資訊 英文 148 Pages
訂單完成後即時交付
價格
Back to Top
微生物定序的全球市場 Global Microbiome Sequencing Market
出版日期: 2019年06月07日內容資訊: 英文 148 Pages
簡介

全球微生物定序市場規模,預計從2018年的8億8500萬美元,到2023年擴大到20億美元,其間為18.2%的年複合成長率。

本報告提供全球網路安全市場相關調查,IT,總括性網路安全,IoT安全,及雲端安全市場上全球安全市場概要,世界市場趨勢分析與預測,主要的機會,IT安全的多樣技術及各技術的市場動態的評估,預計高成長的市場區隔,及企業簡介等相關彙整。

第1章 簡介

第2章 摘要、亮點

第3章 市場、技術背景

  • 市場趨勢
  • 新技術
  • 市場動態

第4章 市場分析:各定序技術

  • Sanger定序
  • 高通量定序
    • SBS法 (Sequencing by Synthesis)
    • SBL法 (Sequencing by Ligation)
    • 霰彈槍定序
    • TGS法 (目標遺傳基因定序)
    • RNA定序
    • WGS (全基因測序)
    • 其他 (甲基化定序)
  • 第3代定序

第5章 市場分析:各零件

  • 試劑、套件
  • 設備
    • 液體搬運設備
    • 網站儀表
    • 影像裝置
    • 微量盤式分析儀

第6章 市場分析:各用途

  • 藥物研發
  • 遺傳基因檢驗
  • 疾病診斷研究
  • 個性化醫療
  • 其他 (治療)

第7章 市場分析:各終端用戶

  • 醫藥品、生物科技
  • 大學中心、研究機關
  • CRO (醫藥品臨床研究委外機構)
  • 其他 (營養)

第8章 市場分析:各實驗室類型

  • 乾實驗室
  • 溼實驗室

第9章 市場分析:各地區

  • 北美
  • 南美
  • MEA
  • 歐洲
  • 亞太地區

第10章 專利檢討/新開發

  • 新開發
  • 專利分析

第11章 市場機會分析

  • 主要供應商、製造商定位、策略
    • Thermo Fisher Scientific Inc.
    • Illumina Inc.
    • Qiagen NV
    • Molzym GmbH & Co. KG
    • Novogene Corp.

第12章 企業簡介

  • ALLELE PTY LTD.
  • BASECLEAR BV
  • BGI
  • BIOLOG INC.
  • BIOMATHEMATICA
  • BIOSPHEREX LLC
  • CHARLES RIVER LABORATORIES INTERNATIONAL INC.
  • CLINICAL MICROBIOMICS A/S
  • COREBIOME INC.
  • COSMOSID INC.
  • DIVERSIGEN INC.
  • EUROFINS GROUP
  • GENOME7
  • GROKEN BIOSCIENCE LTD.
  • HUMAN LONGEVITY INC.
  • ILLUMINA INC.
  • LABCYTE INC.
  • LEUCINE RICH BIO PVT. LTD.
  • MEGHAGEN BIOSCIENCES PVT. LTD.
  • METABIOMICS
  • METAGENOM BIO INC.
  • MICROBIOME INSIGHTS INC.
  • THERMO FISHER SCIENTIFIC INC.
  • MICROBIOME THERAPEUTICS LLC
  • MOLZYM GMBH & CO. KG
  • NORGENBIOTEK CORP.
  • NOVOGENE CORP.
  • OXFORD NANOPORE TECHNOLOGIES LTD.
  • PACIFIC BIOSCIENCES OF CALIFORNIA INC.
  • PHASE GENOMICS INC.
  • PILLAR BIOSCIENCES INC.
  • QIAGEN N.V.
  • RANCHO BIOSCIENCES LLC
  • RESPHERA BIOSCIENCES, LLC
  • READCOOR INC.
  • RITTER PHARMACEUTICALS INC.
  • SECOND GENOME INC.
  • SHORELINE BIOME, LLC.
  • STARSEQ GMBH
  • SYNLOGIC
  • UBIOME INC.
  • VAIOMER
  • VIOME INC.
  • ZYMO RESEARCH CORP.
目錄
Product Code: BIO183A

Report Highlights:

The global market for microbiome sequencing should grow from $885 million in 2018 to $2.0 billion by 2023 at a compound annual growth rate (CAGR) of 18.2% for the period of 2018-2023.

Sanger microbiome sequencing market should grow from $371 million in 2018 to reach $841 million by 2023 at a CAGR of 17.8% for the period of 2018-2023.

High-throughput microbiome sequencing market should grow from $328 million in 2018 to reach $768 million by 2023 at a CAGR of 18.5% for the period of 2018-2023.

Report Scope:

This report provides an elaborate summary of the market, including a market snapshot and company profiles of key players competing in the microbiome sequencing market. It provides an exhaustive segmentation of the market with in-depth information about each segment. The overview section of the report provides a source of description of market trends and market dynamics, which includes drivers, limitations, challenges and opportunities in the market. It provides information about market development and future trends that can be useful for organizations, including wholesalers and exporters. It provides market positioning of key players using the yardsticks of revenue, product portfolio and recent activities. It includes strategies adopted by emerging market players with strategic recommendations for new market entrants. Outright information is provided in the report, consisting of historic and current market size and including the future potential of the market. The report will enable market players and new entrants to make an informed decision about the production and export of goods and services to the original equipment manufacturer.

The market is segmented on the basis of sequencing technology, component, applications, laboratory type and end use. Geographic market analysis is provided for all major segments. The report offers country level analysis of the market to provide better understanding of major segments.

Report Includes:

  • 60 data tables and 17 additional tables
  • An overview of the global market and technologies for genome sequencing within the industry
  • Analyses of global market size and trends, with data from 2017, 2018 and projections of CAGRs through 2023
  • Key outline of present and future market potentials, and factors influencing the microbiome sequencing market
  • Discussion on impact of genome sequencing on pharmaceutical, biotechnology and healthcare sectors
  • Information on automated instruments and discussion on how it facilitates speedy sequencing procedures
  • Insights into government initiatives and funding for the development of effective drugs for the treatment and prevention from chronic diseases
  • Company profiles of the major players of the market, including Biolog Inc., CosmosID Inc., Illumina Inc., Metabiomics and Oxford Nanopore Technologies Ltd.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Market Trends
    • North America Dominates the Microbiome Sequencing Market
    • High-throughput Sequencing: Microbiome Research
    • Automated Instruments
    • AI and Virtual Simulation
  • Novel Technologies
    • Stem Cell Technologies
  • Market Dynamics
    • Key Factors Driving Market Growth

Chapter 4: Market Breakdown by Sequencing Technology

  • Sanger Sequencing
  • High-throughput Sequencing
    • Sequencing by Synthesis (SBS)
    • Sequencing by Ligation (SBL)
    • Shotgun Sequencing
    • Targeted Gene Sequencing (TGS)
    • RNA Sequencing
    • Whole Genome Sequencing (WGS)
    • Others (Methyl Sequencing)
  • Third-generation Sequencing

Chapter 5: Market Breakdown by Component

  • Reagents and Kits
  • Instruments
    • Liquid Handling Instruments
    • Cytometers
    • Imaging Devices
    • Microplate Reader

Chapter 6: Market Breakdown by Application

  • Drug Discovery
  • Genetic Screening
  • Disease Diagnosis Research
  • Personalized Medicine
  • Others (Therapeutics)

Chapter 7: Market Breakdown by End User

  • Pharmaceutical and Biotechnology
  • Academic Centers and Research Institutes
  • Contract Research Organizations (CROs)
  • Others (Nutritional)

Chapter 8: Market Breakdown by Laboratory Type

  • Dry Labs
  • Wet Labs

Chapter 9: Market Breakdown by Region

  • North America
    • The U.S.
    • Canada
  • Latin America
  • MEA
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific

Chapter 10: Patent Review/ New Developments

  • New Developments
  • Patent Analysis

Chapter 11: Analysis of Market Opportunities

  • Key Suppliers and Manufacturers Positioning and Strategy
    • Thermo Fisher Scientific Inc.
    • Illumina Inc.
    • Qiagen NV
    • Molzym GmbH & Co. KG
    • Novogene Corp.

Chapter 12: Company Profiles

  • ALLELE PTY LTD.
  • BASECLEAR BV
  • BGI
  • BIOLOG INC.
  • BIOMATHEMATICA
  • BIOSPHEREX LLC
  • CHARLES RIVER LABORATORIES INTERNATIONAL INC.
  • CLINICAL MICROBIOMICS A/S
  • COREBIOME INC.
  • COSMOSID INC.
  • DIVERSIGEN INC.
  • EUROFINS GROUP
  • GENOME7
  • GROKEN BIOSCIENCE LTD.
  • HUMAN LONGEVITY INC.
  • ILLUMINA INC.
  • LABCYTE INC.
  • LEUCINE RICH BIO PVT. LTD.
  • MEGHAGEN BIOSCIENCES PVT. LTD.
  • METABIOMICS
  • METAGENOM BIO INC.
  • MICROBIOME INSIGHTS INC.
  • THERMO FISHER SCIENTIFIC INC.
  • MICROBIOME THERAPEUTICS LLC
  • MOLZYM GMBH & CO. KG
  • NORGENBIOTEK CORP.
  • NOVOGENE CORP.
  • OXFORD NANOPORE TECHNOLOGIES LTD.
  • PACIFIC BIOSCIENCES OF CALIFORNIA INC.
  • PHASE GENOMICS INC.
  • PILLAR BIOSCIENCES INC.
  • QIAGEN N.V.
  • RANCHO BIOSCIENCES LLC
  • RESPHERA BIOSCIENCES, LLC
  • READCOOR INC.
  • RITTER PHARMACEUTICALS INC.
  • SECOND GENOME INC.
  • SHORELINE BIOME, LLC.
  • STARSEQ GMBH
  • SYNLOGIC
  • UBIOME INC.
  • VAIOMER
  • VIOME INC.
  • ZYMO RESEARCH CORP.

List of Tables

  • Summary Table: Global Market for Microbiome Sequencing, by Sequencing Technology, Through 2023
    • Table 1: Cost Per Genome, 2001-2017
    • Table 2: Global Market for Microbiome Sequencing, by Sequencing Technology, Through 2023
    • Table 3: Sanger Sequencing vs. Targeted NGS
    • Table 4: Global Market for Sanger Sequencing, by Region, Through 2023
    • Table 5: Different NGS Technologies
    • Table 6: Experimental High-throughput Sequencing Technology
    • Table 7: Global Market for High-throughput Sequencing, by Region, Through 2023
    • Table 8: Global Market for High-throughput Sequencing, by Type, Through 2023
    • Table 9: Two-Channel SBS Instruments: Illumina Inc.
    • Table 10: Selected Hybridization Systems: Sequencing Technology
    • Table 11: Amplicon Sequencing vs. Target Enrichment
    • Table 12: First Generation, Second Generation and Third Generation Sequencing
    • Table 13: Global Market for Third-generation Sequencing, by Region, Through 2023
    • Table 14: Global Market for Microbiome Sequencing, by Component, Through 2023
    • Table 15: Global Market for Reagents and Kits Used in Microbiome Sequencing, by Region, Through 2023
    • Table 16: Global Market for Instruments Used in Microbiome Sequencing, by Region, Through 2023
    • Table 17: Global Market for Instruments Used in Microbiome Sequencing, by Type, Through 2023
    • Table 18: Global Market for Microbiome Sequencing, by Application, Through 2023
    • Table 19: Global Market for Microbiome Sequencing in Drug Discovery, by Region, Through 2023
    • Table 20: Global Market for Microbiome Sequencing in Genetic Screening, by Region, Through 2023
    • Table 21: Global Market for Microbiome Sequencing in Disease Diagnosis Research, by Region, Through 2023
    • Table 22: Global Market for Microbiome Sequencing in Personalized Medicine, by Region, Through 2023
    • Table 23: Global Market for Microbiome Sequencing in Others Application, by Region, Through 2023
    • Table 24: Global Market for Microbiome Sequencing, by End User, Through 2023
    • Table 25: Selected Biotech/Pharma Company Partnerships: Microbiome Projects
    • Table 26: Global Market for Microbiome Sequencing in Pharmaceutical and Biotechnology, by Region, Through 2023
    • Table 27: Important Events in NHGRI History, 1990-2016
    • Table 28: Academic Centers and Research Institutes Engaged in Microbiome Research
    • Table 29: Global Market for Microbiome Sequencing in Academic Centers and Research Institutes, by Region, Through 2023
    • Table 30: Global Market for Microbiome Sequencing in CROs, by Region, Through 2023
    • Table 31: Global Market for Microbiome Sequencing in Other End User Segments, by Region, Through 2023
    • Table 32: Global Market for Microbiome Sequencing, by Laboratory Type, Through 2023
    • Table 33: Global Market for Microbiome Sequencing Used in Dry Labs, by Region, Through 2023
    • Table 34: Global Market for Microbiome Sequencing Used in Wet Labs, by Region, Through 2023
    • Table 35: Global Market for Microbiome Sequencing, by Region, Through 2023
    • Table 36: North American Market for Microbiome Sequencing, by Country, Through 2023
    • Table 37: North American Market for Microbiome Sequencing, by Sequencing Technology, Through 2023
    • Table 38: North American Market for Microbiome Sequencing, by Component, Through 2023
    • Table 39: North American Market for Microbiome Sequencing, by Application, Through 2023
    • Table 40: North American Market for Microbiome Sequencing, by End User, Through 2023
    • Table 41: North American Market for Microbiome Sequencing, by Laboratory Type, Through 2023
    • Table 42: Microbiome Research Target Areas
    • Table 43: Cancer Statistics, 2017
    • Table 44: Microbes Designated as Class 1 (Carcinogens), by the IARC
    • Table 45: Colorectal Cancer Mortality Rate, 2011-2015
    • Table 46: Latin American Market for Microbiome Sequencing, by Sequencing Technology, Through 2023
    • Table 47: Latin American Market for Microbiome Sequencing, by Component, Through 2023
    • Table 48: Latin American Market for Microbiome Sequencing, by Application, Through 2023
    • Table 49: Latin American Market for Microbiome Sequencing, by End User, Through 2023
    • Table 50: Latin American Market for Microbiome Sequencing, by Laboratory Type, Through 2023
    • Table 51: MEA Market for Microbiome Sequencing, by Sequencing Technology, Through 2023
    • Table 52: MEA Market for Microbiome Sequencing, by Component, Through 2023
    • Table 53: MEA Market for Microbiome Sequencing, by Application, Through 2023
    • Table 54: MEA Market for Microbiome Sequencing, by End User, Through 2023
    • Table 55: MEA Market for Microbiome Sequencing, by Laboratory Type, Through 2023
    • Table 56: Major Microbiome Research Projects Across Europe, 2017-2018
    • Table 57: European Market for Microbiome Sequencing, by Country/Region, Through 2023
    • Table 58: European Market for Microbiome Sequencing, by Sequencing Technology, Through 2023
    • Table 59: European Market for Microbiome Sequencing, by Component, Through 2023
    • Table 60: European Market for Microbiome Sequencing, by Application, Through 2023
    • Table 61: European Market for Microbiome Sequencing, by End User, Through 2023
    • Table 62: European Market for Microbiome Sequencing, by Laboratory Type, Through 2023
    • Table 63: Expenditures on Research: Crohn's Disease and Ulcerative Colitis, 2009-2014
    • Table 64: Relation of Microbiomes in Advancement of Numerous Diseases
    • Table 65: Asia-Pacific Market for Microbiome Sequencing, by Sequencing Technology, Through 2023
    • Table 66: Asia-Pacific Market for Microbiome Sequencing, by Component, Through 2023
    • Table 67: Asia-Pacific Market for Microbiome Sequencing, by Application, Through 2023
    • Table 68: Asia-Pacific Market for Microbiome Sequencing, by End User, Through 2023
    • Table 69: Asia-Pacific Microbiome Sequencing, by Laboratory Type, Through 2023
    • Table 70: Asia-Pacific Market for Microbiome Sequencing, by Country/Region, Through 2023
    • Table 71: Leading Types of Cancer in Hong Kong, 2005 and 2015
    • Table 72: Selected Developments in Microbiome Sequencing
    • Table 73: Number of Patents for Microbiome Sequencing, by Country/Region, 2016-2019
    • Table 74: Number of Patents on Microbiome Sequencing, by Organization, 2016-2018
    • Table 75: Patents on Microbiome Sequencing, 2016-2019
    • Table 76: Distributors

List of Figures

  • Summary Figure: Global Market for Microbiome Sequencing, by Sequencing Technology, 2017-2023
    • Figure 1: Business Collaboration Benefits
    • Figure 2: Personalized Medicines Approved by the U.S. FDA, 2014-2017
    • Figure 3: Expansion of Human Microbiome Research at NIH, 2012-2016
    • Figure 4: Canadian Cancer Facts, 2017
    • Figure 5: Prevalence of Diabetes in MEA, by Gender, 2017
    • Figure 6: Healthcare Spending in Germany, 2013-2016
    • Figure 7: Mortality Rate: Colorectal Cancer in Germany, by Gender, 2011-2015
    • Figure 8: Mortality from Cancer UK, 2011-2017
    • Figure 9: Colorectal Cancer in France, 2014-2016
    • Figure 10: Incidence of CVD in France, by Gender, 2010 and 2015
    • Figure 11: Colorectal Cancer in Italy, 2015 and 2016
    • Figure 12: Prevalence of CVD in Italy, 2010 and 2015
    • Figure 13: HIV in Spain, 2016
    • Figure 14: Prevalence of CVD in Rest of European Countries, 2010 and 2015
    • Figure 15: Global Burden Disease Database
    • Figure 16: Top Five Cancer Types in Japan, 2017
    • Figure 17: Thermo Fisher Scientific Inc.: Revenue, by Complementary Segment, 2017
    • Figure 18: Thermo Fisher Scientific Inc.: Revenue, by Region, 2017
    • Figure 19: Illumina Inc.: Revenue, by Complementary Segment, 2017
    • Figure 20: Illumina Inc.: Revenue, by Region, 2017
    • Figure 21: Qiagen NV: Revenue, by Complementary Segment, 2017
    • Figure 22: Qiagen NV: Revenue, by Region, 2017
Back to Top